MOLNR J. Molner AS
J. Molner AS (MOLNR) news
J. Molner AS is a public biotech or pharmaceutical company listed on OMXTSE under the ticker MOLNR, recorded under Estonia. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest J. Molner AS news
We have not published a story on J. Molner AS yet. When there is news, it will appear here.
Questions about J. Molner AS
What is the ticker symbol of J. Molner AS?
J. Molner AS trades under the ticker MOLNR on OMXTSE.
Where is J. Molner AS listed?
J. Molner AS is listed on OMXTSE.
Which country or territory is J. Molner AS listed under?
Our directory records J. Molner AS under Estonia.
What does J. Molner AS do?
Our directory classifies J. Molner AS as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of J. Molner AS?
The ISIN recorded for J. Molner AS is EE3100109034.
Does aibio.space cover J. Molner AS?
aibio.space lists J. Molner AS among 2,820 public biotech companies and publishes its news here as stories appear.
Investor discussion: J. Molner AS
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Listing details
- Company
- J. Molner AS
- Ticker
- MOLNR
- Listing
- OMXTSE
- Country or territory
- Estonia
- Business scope
- Pharmaceuticals: Major
- ISIN
- EE3100109034
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio